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Localization of aldose and aldehyde reductase in the kidney. The
distribution of NADPH-dependent reductase activity in the rat cortex,
outer medulla and inner medulla was investigated through biochemical
and histochemical methods. Biochemical studies revealed reductase
activity to be present in all three regions of the kidney with the highest
specific activity observed in the inner medulla, followed by the cortex
and the outer medulla. Activity in all three regions was inhibited by the
aldose reductase inhibitors sorbinil, tolrestat and 7-hydroxychromone-
2-carboxylic acid. Based on substrate utilization and response to sulfate
ion and inhibitors, the inner medulla contains primarily aldose reduc-
tase (EC 1.1.1.21) while the cortex contains primarily aldehyde reduc-
tase (EC 1 .1. 1.2). The outer medulla contains a mixture of both
enzymes. This distribution was confirmed by a radioimmunoassay for
aldose reductase. Immunohistochemical investigations of the rat kidney
with antibodies against rat lens aldose reductase and rat kidney aide-
hyde reductase revealed a similar distribution of these enzymes.
Aldehyde reductase was immunohistochemically detected only in the
cortex where it was localized in the proximal convoluted tubules.
Immunoreactive aldose reductase was detected in Henle's loop at both
the inner stripe of the outer medulla and in the inner medulla, and in the
collecting tubules and the epithelial cell lining the pelvis of the inner
medulla near the papilla. No specific immunohistochemical staining for
aldose reductase was observed in the cortex. A similar immunohisto-
chemical distribution of aldose reductase was also observed in the
human kidney with antibodies against human placental aldose reduc-
tase,
Recent reports suggest that aldose reductase inhibitors may
have a beneficial effect in reversing renal dysfunction in diabetic
rats. Analysis of urine from diabetic rats administered the
aldose reductase inhibitor sorbinil suggest that proteinuria is
diminished [1] and in the glomerulus sorbitol levels are reduced
while myo-inositol levels and Na,K-ATPase activity are
increased [2, 3]. These results imply a link between diabetic
nephropathy and aldose reductase (low km aldehyde reductase,
EC 1.1.1.21), a member of the aldehyde reductase family of
enzymes which utilize NADPH to stereoselectively reduce
aldehydes to their respective alcohols. This enzyme together
with sorbitol dehydrogenase forms the sorbitol pathway in
which glucose is converted to fructose via the intermediate
sugar alcohol sorbitol. In experimental animals the aldose
reductase-initiated intracellular accumulation of sorbitol has
been shown to initiate several diabetic complications including
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cataract, keratopathy, neuropathy, and possibly retinopathy [4,
5].
In addition to aldose reductase, the kidney contains another
aldehyde reductase, ALR1, which is also known as the high km
aldehyde reductase (EC 1.1.1.2) because of its lower affinity for
glucose as a substrate [61. Originally this enzyme was catego-
rized as hexonate dehydrogenase (EC 1.1.1.19) due to its ability
to also catalyze the conversion of alcohols to aldehydes [7].
Current interest in this enzyme stems from the fact that many
aldose reductase inhibitors also inhibit this enzyme [8, 9].
Several studies on the renal localization of aldose reductase
have been conducted; however, the reported results have been
contradictory. Corder et a! [101, employing histochemical tech-
niques in which enzyme activity was assessed by fluorometri-
cally assaying the aldose reductase-catalyzed formation of
glucose from sorbitol, reported aldose reductase activity to be
present in all three regions of the adult rat kidney with activity
highest in the outer medulla and lowest in the inner cortex.
Activity was reported to be specifically localized in the glomer-
uli, the proximal, distal convoluted and collecting tubules, and
in the pars recti and ascending limb of Henle. On the other
hand, Ludvigson and Sorenson [11], using antibodies prepared
against rat seminal vesicle aldose reductase, reported immuno-
reactive staining to be greatest in the inner medulla and papil-
lary tip with immunoreactive aldose reductase present with
certainty in the podocytes, distal convoluted tubules, thin
segments of Henle's loop, collecting tubules, and papillary
ducts of the inner medulla and transitional epithelium in the
pelvic space. Their antibodies, however, failed to demonstrate
the presence of aldose reductase in the corneal epithelium, a
structure known to contain the aldose reductase [4], thus
leaving open the possibility that their observed discrepancies
with Corder, Braughler and CuIp could result from technical
problems. In the human kidney, Corder et a! have observed
aldose reductase activity in the glomeruli [12]. Examining
human kidney with antibodies raised against human brain
aldose reductase and liver aldehyde reductase, Wirth and
Wermuth [13] reported aldose reductase to be increased in the
medulla but present throughout the entire tubular system.
Moreover, they reported the presence of aldehyde reductase in
the proximal tubules, Henle's loop and distal and collecting
tubules; however, these results are not accompanied by pub-
lished photographs.
In order to clarify these conflicting reports and gain insight
into the potential role of aldose reductase in nephropathy, the
localization of NADPH-dependent reductases in the rat kidney
843
844 Terubayashi et a!: A/dose and aldehyde reductase
has been investigated through complementary biochemical and
immunohistochemical methods. In addition, the immunohisto-
chemical investigation of aldose reductase in the human kidney
has been conducted.
Methods
All chemicals employed were of reagent grade or as previ-
ously described [14]. IODO-BEADS were obtained from Pierce
Chemical Company (Rockford, Illinois, USA). Sodium
'25lodide (506 mCi/mi in water, pH 8 to 10) was obtained from
New England Nuclear (Boston, Massachusetts, USA). Fluores-
cein isothiocyanate-conjugated anti-goat IgG was obtained from
Miles Laboratories (Elkhart, Indiana, USA), rabbit anti-goat
gamma-globulin was obtained from Calbiochem-Boehring (La
Jolla, California, USA), and RIA grade bovine serum albumin
(BSA) was obtained from Sigma Chemical Co. (St. Louis,
Missouri, USA).
Biochemical Assay
Female Sprague-Dawley rats weighing 250 to 300 g were
anesthetized with sodium pentobarbital and perfused with ice-
cold saline solution. The perfused kidneys were removed, split
longitudinally, and the cortex, outer medulla and inner medulla
regions were then carefully dissected out. Each discrete region
was homogenized in 5 to 10 volumes of distilled water and
centrifuged at 12,500 x g for 20 minutes. The remaining
supernatant was used as the enzyme source.
Isolated rat kidney glomeruli were prepared by chopping
dissected cortex into 0.5 to 1 mm cubes and pushing them
through a 150 pm stainless steel sieve. The passed through
material was re-suspended in phosphate buffered saline (PBS),
placed in a syringe and passed through an 18 to 20 gauge needle.
The remaining suspension was then passed through a 70 to 80
m nylon mesh. With this procedure, about 1 ml of intact
glomerulus suspension in the PBS, confirmed by light micros-
copy, was obtained from four kidneys. This suspension was
homogenized in a glass homogenizer and centrifuged at 10,000
x g for 10 minutes. The remaining supernatant was used as the
enzyme source.
Reductase activity was spectrophotometrically determined
on a Guilford Response Spectrophotometer by following either
decreases in the concentration of NADPH at 340 nm with either
10 mM DL-glyceraldehyde, D-glucose, D-glucuronate, D-xy-
lose as substrates or the increase of NADPH with L-gulonate as
substrate [14]. Inhibitor IC50 determinations were conducted as
previously described using 10 m DL-glyceraldehyde as sub-
strate [15].
Protein determinations
Proteins were spectrophotometrically determined at 595 nm
by the method of Bradford [161.
Antibodies
Antibodies against aldose reductase were raised in goats
against aldose reductase purified from either human placenta
[14] or rat lens [17]. Antibodies against aldehyde reductase were
raised in goat against aldehyde reductase purified from rat
kidney [18]. The specificity of all antibodies were confirmed by
Western blots (Fig. 1) visualized with Vectastain (Vector Labs,
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Fig. 1. Western blots illustrating the specificity of antibodies raised
against purified rat lens a/dose reductase (RLAR) and rat kidney
aldehyde reductase (RKAR) to crude whole rat kidney homogenate,
isolated crude rat kidney medulla homogenate, purified rat lens a/dose
reductase (AR) and purified rat kidney aldehyde reductase (ALR). A
illustrates proteins separated by relative molecular weights on sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and visual-
ized by Comassie Blue staining. Lane 1 contains the molecular weight
standards (MWS) phosphorylase b (94K), bovine serum albumin (67K),
ovalbumin (43K), carbonic anhydrase (30K), soybean trypsin inhibitor
(20K) and a-lactalbumin (14.4K). B represents the immunoblot obtained
following electrophoretic transfer of A onto nitrocellulose, reaction of
the immobilized proteins with antibodies against RKALR, and visual-
ization of the immune complex with peroxidase labeled IgG. C repre-
sents a similar immunoblot using antibodies against RLAR.
Compiegne, France) [19]. For immunohistochemical staining all
sera were diluted with PBS containing 0.3% Triton X-lOO.
lodination of rat lens aldose reductase
Five IODO-BEADS were washed with 5 ml of PBS and
blotted dry on filter paper. These were then added to a
container containing 480 d of PBS and 20 pi of aqueous Na'251.
After standing five minutes, 200 p.g of purified rat lens aldose
reductase [20] in 2.0 ml of PBS was added and the mixture was
allowed to stand for 15 minutes. The entire mixture was then
placed on a disposable Sephadex G-25 column (Pharmacia
Diagnostics, Piscataway, New Jersey, USA) and iodinated
aldose reductase was eluted with 3 ml of PBS.
Radioiminunoassay of aldose reductase
Samples containing aldose reductase (0.1 ml) were added to
tubes containing 0.7 ml of 0.1 M PBS, pH 7.4 with 1% bovine
serum albumin (BSA), 0.1 ml 1251-labeled rat lens aldose reduc-
tase (105 CPM/ml), and 0.1 ml of antiserum raised against rat
lens aldose reductase (adjusted to bind about 50% of radiola-
beled aldose reductase) and stored for 18 hours at 4°C. Next,
immunoblot (Rat kidney)
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Table 1. NADPH-dependent reductase activity with DL-
glyceraldehyde as substrate in rat kidney homogenates and its
inhibition by aldose reductase inhibitors
Enzyme
Inhibitor IC50 pM
7-Hydroxy-
activity chromone-
/.LM/min/mg 2-carboxylic
Kidney region protein Sorbinil Tolrestat acid
Cortex 52 2.7 0.7 5.7
Outer medulla 8.7 3.5 0.7 15
Inner medulla 128 0.01 0.02 1.6
0.1 ml of 50% of rabbit anti-goat gamma-globulin and 0.1 ml of
10% normal goat serum were added to each tube and the
reaction mixtures were incubated at 37°C for one hour. After
cooling in an ice bath, each tube was centrifuged at 10,000 g for
two minutes at 4°C, and a I ml aliquot of supernatant was
counted in a Beckman Gamma 5500 counter (Beckman Instru-
ments, Fullerton, California, USA).
The quantity of aldose reductase in each sample was deter-
mined by comparisons to a standard curve constructed by the
addition of known amounts of unlabeled aldose reductase to
radiolabeled enzyme. Serial dilutions were made of each un-
known sample to give five different concentrations of aldose
reductase protein ranging between 5 ng and 10 tg, and each
determination was made in triplicate.
Immunohistochemical methods
Female Sprague-Dawley rats weighing 250 to 300 g were
anesthetized with sodium pentobarbital and perfused with ice-
cold saline solution. This was immediately followed by perfu-
sion with a fixative of 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4. After perfusion, the kidneys were immediately
removed and fixed an additional 6 to 12 hours with 4% para-
formaldehyde in 0.1 M phosphate buffer at 4°C.
Human kidneys segments, frozen less than 10 hours post-
mortem were obtained from non-diabetic adults through the
National Diabetes Research Interchange (NDRI). The frozen
segments of human kidney were thawed and fixed for 24 hours
in 4% paraformaldehyde in 0.1 M phosphate buffer at 4°C.
Fixed kidney segments were washed with graded solutions of
sucrose (10, 15 and 20%) in 0.1 M phosphate-buffered saline, pH
7.4. Both transverse and longitudinal frozen sections (10 to 16
sm) cut along Henle's loop were prepared and placed into PBS
containing 0.3% Triton X-lOO at 4°C for two to three days. The
sections were immersed in normal bovine serum (x 100) for one
hour and then treated overnight at 4°C with primary antibodies
(either anti-rat lens aldose reductase x5000;anti-human placen-
tal aldose reductase x3000; anti-rat kidney aldehyde reductase
x5000). This was followed by treatment (2 hr) with fluorescein
isocyanate-conjugated rabbit anti-goat immunoglobins (Miles
Laboratories) and washing with PBS without Triton X- 100. The
sections were then infiltrated with glycerol/PBS (1:2) and ex-
amined on a Leitz Ortholux 2 microscope equipped with a
Ploemopak 2,2 fluorescence vertical illumination at 546 nm
excitation wavelength. For controls, sections were treated with
either primary antibodies absorbed with purified antigen or
normal goat serum. No specific immunoreactive staining was
detected in these sections.
Table 2. Effect of substrates on the relative activity of NADPH-
dependent reductase activity in rat kidney homogenates
Percent relative activity
Outer Inner
Substrate Cortex medulla medulla
DL-glyceraldehyde 100 100 100
D-glucose 1 1 3
D-glucuronate 138 105 22
D-xylose 2 5 23
L-gulonate 4 3 0.3
DL-glyceraldehyde
+0.2 M Li2SO4 98 129 190
+ 1 mM valproate 31 53 85
Results
Rat kidney studies
Biochemical studies. Perfused kidneys from adult female rats
were carefully dissected into regions containing cortex, outer
medulla and inner medulla. Analysis of the homogenates from
each dissected region for NADPH-dependent reductase activity
with DL-glyceraldehyde as substrate revealed that the highest
specific activity was observed in the inner medulla, followed by
the cortex, and finally the outer medulla region (Table I). This
reductase activity was inhibited by micromolar concentrations
of the aldose reductase inhibitors sorbinil, tolrestat, and 7-
hydroxychromone-2-carboxylic acid (Table 1). Further exami-
nation of each homogenate with D-glucose, D-glucuronate,
L-gulonate and D-xylose as substrates indicated that enzyme
activity in the inner medulla was maintained with xylose >
glucuronate > glucose > gulonate while enzyme activity in the
cortex was maintained with glucuronate >gulonate > xylose>
glucose (Table 2). In the inner medulla reductase activity was
stimulated by the presence of 200 m lithium sulfate and only
slightly inhibited by the presence of 1 mtvt vaiproic acid. In the
cortex, reductase activity was not stimulated by the addition of
lithium sulfate and the presence of valproate resulted in 69%
inhibition of reductase activity. Based on substrate utilization
and inhibitor criteria that characterize NADPH-dependent re-
ductases which utilize D-glucuronate, L-gulonate, and are
substantially inhibited by 1 mr.t valproate as aldehyde reduc-
tases (ALR1, EC 1.1.1.2) and those which utilize D-xylose, are
stimulated by sulfate ion and not substantially inhibited by I
mM valproate as aldose reductase (ALR2, EC 1.1.1.21) [21],
these observations suggest that the inner medulla contains
predominantly aldose reductase while the cortical region con-
tains predominantly aldehyde reductase. The outer medulla
region, which displays results intermediate between the cortex
and inner medulla (Table 2) probably contains a mixture of both
reductases. Such a conclusion was strengthened by a radioim-
munoassay (RIA) for aldose reductase which indicated levels of
6.07 0.94 pg/mg protein in the homogenate of inner medulla,
0.85 0.17 jzglmg protein in the outer medulla and 0.22 0.03
p.g/mg protein in the cortex.
Immunohistochemical studies. Examination of frozen sec-
tions of rat kidney with antibodies prepared against purified rat
lens aldose reductase also indicated aldose reductase to be
predominantly present in the inner medulla. In longitudinal
sections, the histochemical presence of aldose reductase was
primarily observed in Henle's loop of the inner medulla but not
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Fig. 3. Immunohistochemical localization of aldose reductase in transverse sections of rat kidney. In A immunoreactive staining is observed in
the thick ascending limbs of Henle's loop located in the inner stripe of the outer medulla (x88). In B essentially all cells of Henle's loop located
in the outer zone of the inner medulla display immunoreactive staining while the collecting tubules in the enlargement C do not. (B x88; C x 144)
In the inner zone of the inner medulla aldose reductase staining occurs in both Henle's loop cells and collecting tubules (D x360).
of the outer medulla (Fig. 2A). However, some staining of the
thick ascending limbs of Henle's loop in the inner stripe of the
outer medulla was observed (Figs. 2C, 3A). In the inner
medulla, immunoreactive aldose reductase appeared localized
in the thin limbs of Henle's loop which displayed a character-
istic protrusion of nuclei into the lumen (Figs. ID, E, 2B). No
immunoreactive staining of the collecting tubules in the outer
zone of the inner medulla were observed. In the inner zone of
Fig. 2. Immunohistochemical localization of aldose reductase in longitudinal sections of rat kidney. Henle's loop cells in the inner medulla
demonstrate strong immunoreactive activity with antibodies raised against purified rat lens aldose reductase (A), while no specific immunoreactive
staining is observed in the control (B) where antibodies preabsorbed with purified rat lens aldose reductase were employed. (OM, outer medulla;
IM, inner medulla. A,B x 105). Immunoreactive staining can be observed in the thick limbs of Henle's loop in the inner stripe of the outer medulla
(C, arrows x225) and the thin limbs of Henle's loop in the inner medulla (D X 135). E is a higher magnification of D and illustrates that these
immunoreactive cells display a protrusion of nuclei into the lumen which characteristic of the cells of the thin limbs of Henle' s loop (X 300). In the
inner zone near the papilla of the inner medulla, immunoreactive staining for aldose reductase can be observed in Henle's loop, collecting tubules
(c) and the epithelial cells lining the pelvis (F x 105).
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Fig. 4. Immunohistochemical localization of aldehyde reductase in the rat kidney using antibodies prepared against purified rat kidney aldehyde
reductase. In the section of cortex, A, the presence of aldehyde reductase can be demonstrated in the proximal convoluted tubules but not in the
glomeruli (arrows) (x 102). No specific staining is observed in the control B (x 170). C represents a higher magnification of the cortex illustrating
the absence of immunoreactive staining for aldehyde reductase in the glomerulus (arrow) (x 170). In sections of the medulla (D) and its control (E)
no specific staining for aldehyde reductase can be detected in either the outer medulla (om) or inner medulla (im) (X 102).
Table 3. NADPH-dependent reductase activity in isolated
rat kidney glomeruli
Substrate
Enzyme activity
nmol/min/mg
protein
DL-glyceraldehyde 15.8
D-gluduronate 17.7
D-xylose 1.0
D-glucose 0.3a
a Estimated due to low activity
the inner medulla, near the papilla, immunoreactive staining
was observed in both Henle's loop and the collecting tubules,
and the epithelial cell lining the pelvis (Figs. 2F; 3D). No
reproducible, specific immunoreactive staining for aldose re-
ductase was observed in the cortex; however, weak immuno-
reactive staining of glomerular podocytes and distal convoluted
tubules similar to that described by others [11] was occasionally
observed.
Table 4. Comparison of relative NADPH-dependent reductase
activity to purified rat kidney aldehyde reductase (RKALR) and rat
lens aldose reductase (RLAR)
Substrate
Relative activity %
Glomerulus RKALR RLAR
DL-glyceraldehyde 100 100 100
D-glucuronate 112 125 25
D-xylose 6.2 0.7 26
D-glucose 1.8 <0.1 2.1
Similar examination of rat kidney with antibodies prepared
against purified rat kidney aldehyde reductase indicated immu-
noreactive staining for aldehyde reductase to occur predomi-
nantly in the cortex. This immunohistochemical staining for
aldehyde reductase was localized in the proximal convoluted
tubules but not in the glomeruli (Fig. 4A, C). No specific
immunoreactive staining for aldehyde reductase was observed
in either the outer or inner medulla (Fig. 4D).
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Fig. 5. Immunohistochemical localization of a/dose reductase in the human kidney using antibodies prepared against human placental aldose
reductase. Transverse sections of the inner medulla (A x 130) demonstrate the presence of immunoreactive aldose reductase in the both Henle's
loop (small arrows in inset enlargement x355) and the collecting tubules (large arrows in inset enlargement). No specific immunoreactive staining
could be observed in the control (B x 130). The bright dots in B represent nonspecific autofluorescence of erythrocytes. In the cortex (C) and its
control (D), no specific staining for aldose reductase could be observed (x 250). Note the absence of staining by the glonierulus (arrows).
Isolated glomeruli. Because of the failure to immunohisto-
chemically detect aldose reductase in the kidney cortex, prep-
arations of isolated glomeruli were also examined. Enzymatic
examination of the isolated glomeruli homogenates indicates
that on a specific activity basis, approximately 170-fold less
NADPH-dependent reductase activity is observed compared to
whole cortex homogenates with glyceraldehyde as substrate
(Table 3). Similar activities were observed with glucuronate as
substrate and activity decreased with either xylose or glucose.
Comparison of the relative NADPH-dependent reductase activ-
ity to either purified rat lens aldose reductase and rat kidney
aldehyde reductase (Table 4) suggests that the glomeruli contain
both enzymes.
Human kidney studies
The immunohistochemical localization of aldose reductase
was also investigated in the human kidney with antibodies
prepared against human placental aldehyde reductase. In the
inner medulla immunoreactive staining for aldose reductase
appeared localized in Henle's loop and in the collecting tubules
(Fig. 5A). In the cortex, no specific staining was found in either
the glomerulus or proximal or distal convoluted tubules (Fig.
5C).
Discussion
Several reports suggest that aldose reductase inhibitors are
beneficial in altering the pathogenesis of diabetic nephropathy
in rats and they imply that these beneficial effects stem primar-
ily from the inhibition of glomerular aldose reductase. Although
aldose reductase has been observed to be present in kidney
tissues [10—13, 22—24], many of these reports present conflicting
results as to the localization of aldose reductase in the kidney.
Therefore, the localization of NADPH-dependent reductases in
the rat kidney has been reinvestigated through complementary
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biochemical and immunohistochemical methods. In addition,
the immunohistochemical investigation of aldose reductase in
the human kidney has been conducted.
Biochemical examination with glyceraldehyde as substrate
reveals NADPH-dependent reductase activity to be present in
all three regions of the kidney with highest specific activity
observed in the inner medulla, and the reductase activity in all
three regions was inhibited by the aldose reductase inhibitors
sorbinil, toirestat and 7-hydroxychromone-2-carboxylic acid.
Based on substrate specificities and inhibitor sensitivities, the
cortex has been observed to contain primarily aldehyde reduc-
tase, the inner medulla contains primarily aldose reductase, and
the outer medulla contains a mixture of both enzymes. This was
confirmed by subsequent quantification of aldose reductase in
all three homogenates by RIA which revealed that on a tg/mg
protein basis 85% of aldose reductase was in the inner medulla
with 12% in the outer medulla and 3% in the cortex.
Immunohistochemical investigations of the rat kidney with
antibodies against rat lens aldose reductase and rat kidney
aldehyde reductase also revealed a similar distribution of these
enzymes. In the cortex, no specific staining for aldose reductase
was observed and specific immunohistochemical staining for
aldehyde reductase was detected only in the proximal convo-
luted tubules. In the outer and inner medulla, no specific
immunoreactive staining for aldehyde reductase was observed.
Specific immunoreactive aldose reductase was detected in
Henle's ioop at both the inner stripe of the outer medulla and in
the inner medulla; and, in the collecting tubules and the
epithelial cell lining the pelvis of the inner medulla near the
papilla. A similar immunohistochemical distribution of aldose
reductase was also observed in the human kidney with antibod-
ies against human placental aldose reductase. Immunoreactive
aldose reductase was only observed in Henle's loop and col-
lecting tubules of the inner medulla. No staining of the glomer-
ulus or distal convoluted tubules was observed.
These results are in general agreement with previous immu-
nohistochemical studies of aldose reductase in the rat [11] and
dog [22] and in the biochemical studies of Hutton et al [23]. Our
results, however, contradict the biochemical studies of Corder
et al [10] who claim that aldose reductase activity in the rat
kidney is highest in the outer medulla and particularly in the
convoluted tubules, and question the histochemical studies of
Corder, Braughier and Cuip [12] which report the strong
presence of aldose reductase in the glomerulus. Our results also
question the observations of Wirth and Wermuth [13], who
report that aldose reductase is distributed throughout the entire
human kidney tubular system and that aldehyde reductase is
distributed in mainly the proximal tubules, but is also present in
Henle's loop, and in the distal and collecting tubules.
Due to technical and sensitivity limitations, a direct demon-
stration of the presence of aldose or aldehyde reductase through
immunohistochemical techniques is difficult. Therefore, failure
to detect the presence of the enzyme through this technique
does not necessarily mean the absence of this enzyme in the
system. For example, although immunohistochemically we can
not successfully demonstrate the immunohistochemical pres-
ence of aldose reductase in the cortex, especially in the glomer-
ulus, the more sensitive RIA technique does indicate that
aldose reductase is present in the cortex. Since NADPH-
dependent reductase activity corresponding to aldose and aide-
hyde reductase has been observed in isolated glomeruli and
polyol formation has been demonstrated in intact isolated
glomeruli [2], it appears that both enzymes are present in the
glomeruli at levels below the threshold of detection. Aldose
reductase has also been reported to be present in tissue cultured
messangial cells [24].
It has been suggested that the aldose reductase initiated
accumulation of sorbitol may play a physiological role by
serving as an osmolyte in kidney tubule cells [25, 26]. The
predominant presence of aldose reductase in the collecting
tubules adds support to such a postulate.
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